Buckingham Strategic Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $701K | Buy |
8,987
+961
| +12% | +$74.9K | 0.01% | 399 |
|
|
2024
Q1 | $544K | Buy |
8,026
+255
| +3% | +$17.3K | 0.01% | 440 |
|
|
2023
Q4 | $523K | Buy |
7,771
+1,770
| +29% | +$119K | 0.01% | 430 |
|
|
2023
Q3 | $406K | Sell |
6,001
-615
| -9% | -$41.6K | 0.01% | 463 |
|
|
2023
Q2 | $474K | Buy |
6,616
+314
| +5% | +$22.5K | 0.01% | 433 |
|
|
2023
Q1 | $427K | Hold |
6,302
| – | – | 0.01% | 414 |
|
|
2022
Q4 | $427K | Buy |
6,302
+481
| +8% | +$32.6K | 0.01% | 416 |
|
|
2022
Q3 | $319K | Sell |
5,821
-160
| -3% | -$8.77K | 0.01% | 454 |
|
|
2022
Q2 | $395K | Sell |
5,981
-92
| -2% | -$6.08K | 0.01% | 417 |
|
|
2022
Q1 | $403K | Buy |
6,073
+50
| +0.8% | +$3.32K | 0.01% | 407 |
|
|
2021
Q4 | $351K | Sell |
6,023
-408
| -6% | -$23.8K | 0.01% | 440 |
|
|
2021
Q3 | $386K | Buy |
6,431
+1,178
| +22% | +$70.7K | 0.01% | 413 |
|
|
2021
Q2 | $315K | Buy |
5,253
+31
| +0.6% | +$1.86K | 0.01% | 454 |
|
|
2021
Q1 | $260K | Buy |
5,222
+954
| +22% | +$47.5K | 0.01% | 465 |
|
|
2020
Q4 | $213K | Buy |
4,268
+381
| +10% | +$19K | 0.01% | 496 |
|
|
2020
Q3 | $213K | Buy |
+3,887
| New | +$213K | 0.02% | 442 |
|
|
2020
Q2 | – | Sell |
-4,932
| Closed | -$220K | – | 412 |
|
|
2020
Q1 | $220K | Buy |
4,932
+787
| +19% | +$35.1K | 0.02% | 410 |
|
|
2019
Q4 | $207K | Buy |
+4,145
| New | +$207K | 0.02% | 434 |
|
|
2014
Q2 | – | Sell |
-7,024
| Closed | -$228K | – | 176 |
|
|
2014
Q1 | $228K | Buy |
+7,024
| New | +$228K | 0.11% | 129 |
|